The income of regional general hospitals in Zhejiang Province (Pinghai Hospital of Hangzhou Stomatological Hospital) was 354 million yuan, accounting for 3 1.39%, and the income of regional branches was 7.74, accounting for 68.6 1%. This is related to the mode of "regional comprehensive hospital+branch" insisted by Tongce Medical College, which was implemented on 20 10. Up to now, Tongce Medical has basically formed a regional hospital cluster of "regional hospitals+branches". There are three general hospitals in Hangzhou Stomatological Hospital: Zhejiang Pinghai Hospital, Chengxi Hospital and Ningbo Stomatological Hospital, forming four regional medical groups: Pinghai Group, Chengxi Group, Ningbo Group and Shaoxing Group.
Fifteen years after listing, the dividend was only 565,438+0,302, and the market development in 400 yuan and other provinces was frustrated.
Tongce Medical is a leading chain dental service enterprise in China. Since its name was changed to "ST Tongce" in 2007, the stock price has risen gratifying, up nearly 20 times so far, with a market value of over 100 billion, and it is known as "Tooth Grass".
In recent years, the performance of Tongce Medical has maintained continuous growth. From 20 17 to 2020, the company's revenue was11800,000 yuan,15.69 million yuan,1931880,000 yuan respectively, and its net profit was 21respectively.
However, since the reorganization and listing of Tongce Medical, only two cash dividends have been implemented, with cash dividends of 465,438+0,683,200 yuan in 2065,438+07 and 966,543+0.92 million yuan in 2065,438+07. Since the company went public 15 years ago, the accumulated net profit has exceeded 2.3 billion yuan. According to this calculation, the dividend rate of Tongce Medical is only 2.2%.
For the reason of not paying dividends, Tongce Medical said that the retained earnings will be used for the development of its main business. Taking 2020 as an example, undistributed profits will be used for the construction of projects such as Chengxi General Hospital and Ningbo General Hospital and the development of "Dandelion" plan.
Dandelion plan is one of the main strategies of Tongce Medical in recent years. It is planned to build 100 branches in counties and key towns in Zhejiang Province within 3-5 years. As of April this year, Tongce Medical has opened 33 hospitals in Zhejiang Province.
Different from the "blooming everywhere" in the province, the road for Tongce Medical to get out of the province is quite rugged. As early as 2007, Tongce Medical acquired Beijing Jingchao Stomatological Hospital and began to explore the market outside the province. Due to poor brand, it was renamed Beijing Tongce Jingchao Stomatological Hospital in 2008. This hospital has been badly run and has been losing money for years. The data shows that the loss in 20 15 years was 2 192400 yuan, and the loss in the first three quarters was 20 1 16700 yuan. On 20 16, Tongce Medical incubated it in vitro in a listed company and renamed it Beijing Cunji Stomatological Hospital again.
Since then, Tongce Medical has also tried to build its own hospital in Beijing. 20 16 10, Tongce Medical announced the construction of Beijing Stomatological Hospital of China Academy of Sciences, with 500 dental chairs and 60 beds, according to the planning and construction of the third-class first-class stomatological hospital. However, after 20 16, Beijing Stomatological Hospital of Chinese Academy of Sciences almost disappeared in the publicity of legal medical care.
In addition to Beijing, Tongce Medical has also tried to expand the markets in Wuhan, Chongqing, Xi, Shanghai and Guangzhou, but judging from the main subsidiaries announced in this year's semi-annual report, the effect is not good. In the analysis of major shareholding companies, there are four hospitals outside the province, namely Cangzhou Stomatological Hospital, Kunming Stomatological Hospital, Yiyang Stomatological Hospital and Kunming Maternal and Child Health and Reproductive Hospital. The total net profit of the four hospitals was 22,435,654,38+0,000 yuan, accounting for 6.27% of the total net profit.
Glen continued to increase his holdings of funds managed by Zhang Kun and Sun Qingrui, ranking among the top ten shareholders.
In April this year, in the quarterly report of Tongce Medical, a number of star funds ranked among the top ten shareholders. Among them, in the first quarter of 20021,the China-Europe medical and health mixed fund managed by "medicine goddess" Gulen increased by 4,509,200 shares, with an increase of 100. 18%. By the end of the first quarter, CEIBS Medical and Health Fund held 90 1.3 million shares, accounting for 2.8 1%, making it the fourth largest shareholder of Tongce Medical.
It is worth mentioning that the Swiss Banking Fund No.6 of Gaoyi Qingrui, a subsidiary of well-known privately-owned Gaoyi Assets, entered 10 as the largest shareholder in the first quarter, holding 272 140 shares, with a shareholding ratio of 0.85%. The fund manager is Sun Qingrui, a well-known female fund manager.
Different from the operation of two female fund managers, Zhang Kun's E Fund reduced its position by 2.3 million shares in the first quarter, with a shareholding ratio of 2. 18%. In the second quarter of this year, Zhang Kun continued to lighten its position by 6,543.8+0.2 million shares of Tongce Medical, and its shareholding ratio dropped to 654.38+0.865.438+0%.
Although the shareholding ratio has decreased, Tongce Medical became the largest heavyweight stock in E Fund's small and medium-sized (11001) hybrid fund in the second quarter, with a position ratio of 8.3 1%.
Glen continued to supplement general medical care. As of June 30th, 20021year, China Europe Medical and Health Fund held 9,862,200 shares of Tongce Medical, and its shareholding ratio rose to 3.08%, making it the fourth largest shareholder of Tongce Medical.
Gaoyi Assets is still the tenth largest shareholder of Tongce Medical, and the number of shares held is the same as that in the first quarter, neither increasing nor decreasing.